Prospective StudentsCurrent StudentsDepartmentsDegree ProgramsFaculty & StaffDevelopmentCalendars

The Center for Medication Use, Policy, and Economics

College of Pharmacy, College of Engineering Degree Program in Pharmaceutical Engineering

New Directions at the College of Pharmacy

Patrick McKercher is a man on a quest.

As director of the new Michigan Center for Medication Use, Policy, and Economics (CMUPE) established last July by the College of Pharmacy and the Medical Center, McKercher's mandate is to create a semiautonomous organization, which supports the missions of the College and University Pharmaceutical Services. This he will do through outcomes and policy research, which bolster the responsible use of pharmaceutical therapies.

As the Center's chief administrator, his second main objective is to make the Center financially self-sufficient. This he plans to achieve by identifying new research opportunities inside and outside the University health system, and then assembling teams of collaborators University-wide who can help him deliver high-level research and consulting.

A big assignment? Yes, but nothing McKercher hasn't done before. For three years prior to joining the College of Pharmacy faculty, he was executive director of the Center on Drugs and Public Policy at the University of Maryland. From 1985 to 1996, he was an employee of Pharmacia & Upjohn, Inc., where, as executive director of corporate policy initiatives, his responsibilities included analysis of legislation and legislative proposals and the initiation of policy research. He spent 12 years before that on the faculties of Wayne State University and the University of Rhode Island, and early in his career was director of pharmacy at Muskegon General Hospital.

"Our plan is not only that CMUPE is self-supporting, but also profitable," says McKercher. "We will run an independent research operation with a profit-oriented focus. Our goal is to bring in sufficient funding to carry out projects, but with a profit margin built in so that there is money to sustain the ongoing operation and to launch new initiatives. In the process, we will create exciting research opportunities for graduate students, junior faculty, research fellows, and even PharmD students."

The College is not unique in having a center of this type, McKercher says, adding that there are at least nine similar centers already in existence, all of them affiliated with pharmacy or medical schools. What makes the Michigan Center for Medication Use, Policy, and Economics different and better is its willingness to work with all types of clients.

"Some academic research centers have an adversarial attitude toward the pharmaceutical industry, while others are funded entirely by industry," McKercher notes. "Even within the industry-funded market some centers have sub-specialties. I know of one academic center that specializes in training pharmaceutical sales reps in pharmacoeconomic concepts so they can talk knowledgeably about cost-benefit analysis vs. cost-effective analysis vs. utility analysis with physicians, pharmacists, and managed care administrators. Another center is almost exclusively funded by a single pharmaceutical manufacturer.

"Each of the customer groups served by these centers has a different philosophical orientation toward drug policy, the use of pharmaceuticals, and pricing. The research centers who conduct the research often reflect these orientations. Our goals are to match expertise with customer needs."

"My hope is to have a balance of funding from private enterprises such as the pharmaceutical industry, from volunteer associations and patient advocacy groups, from professional societies, and from state and federal government. A balance will give us a higher level of credibility and allow us to avoid the illusion that we are advancing any philosophy other than responsible medication use. I think it's healthy for an academic unit to be able to entertain all those philosophies and to accommodate them. It keeps you objective and neutral and, in the end, results in better research."

McKercher notes that when he was at Upjohn, he was in the business of commissioning policy and economic research such as those the Center will carry out.

"I did not believe then, or now, that the goals of a research organization and my industry employer were irreconcilable," he adds. "Obviously sponsors will always try to stretch the researcher to say as much positive as they possibly can. It's a delicate balance, but mature researchers can manage it."

"CMUPE's likelihood of success is enhanced significantly by its University of Michigan affiliation," McKercher says.

"Researchers at the University and at the College of Pharmacy have impeccable reputations around the U.S. and the world. You don't have to sell the quality of the institution, or the quality of its research; they sell themselves. The Center's job is to create the necessary linkages so that we can pursue research initiatives encompassing multiple projects derived from a common theme."

McKercher uses this recent Center initiative to illustrate his point:
Direct-to-consumer advertising is rapidly approaching $3 billion a year, but opinion is mixed on whether this is a good or a bad trend. Anecdotal surveys show that doctors feel they are being badgered by patients misled by self-serving ads and are thus under increasing pressure to prescribe drugs they don't necessarily believe in. The pharmaceutical industry claims that providing such information is a public service. Formulary-driven managed care organizations oppose any direct-to-consumer advertising that attempts to circumvent their authority to set spending limits. Some patient advocate groups share industry's viewpoint, others side with physicians. So what's the real story? Does direct-to-consumer advertising result in better informed consumers? Or are there unintended consequences of having more informed consumers?

McKercher met with researchers from the Schools of Public Health, Business, Medicine, and the College of Pharmacy, and from these consultations has put together a portfolio of four proposals that address various aspects of the direct-to-consumer advertising question. He is now calling on pharmaceutical manufacturers and managed care organizations to underwrite various parts of the project.

"It's not simply a matter of having a set product up front that you go out and sell," McKercher says. "It's more a matter of seeing opportunity and pursuing it by convincing interested parties to enter into a partnership with you. That's what this Center is all about: partnerships."


Sitemap | Feedback | Faculty&Staff Intranet | University of Michigan
428 Church Street / Ann Arbor, MI 48109-1065 / (734) 764-7312
©2003 / page last modified: Thursday, 06-Mar-2003 13:55:07 EST